Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Dow Jones Rallies As Apple Jumps Ahead Of WWDC 2022; Twitter Dives On Elon Musk Filing

The Dow Jones Industrial Average rallied 200 points Monday, as Apple jumped ahead of the company's WWDC 2022 event, while Twitter stock dived.

Investors Business Daily

Dow Jones Sells Off After Jobs Report; Tesla Tumbles On Elon Musk Warning

The Dow Jones Industrial Average dropped after the jobs report. Tesla skidded after Musk said he had a "super bad feeling" about the economy.

Investors Business Daily

Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer

Regeneron stock tumbled Thursday after the company announced a deal to acquire the international rights to Sanofi-partnered cancer drug Libtayo.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Ex-Merck CEO Ken Frazier and his coalition of business leaders plan to hire or promote 1M Black workers

It's called the "bachelor barrier" — the undergraduate degree requirement that many African American and other people of color don't meet, which keeps them from a promotion or a new job.

The Philadelphia Inquirer

Dow Jones Rallies As Salesforce Surges 14% On Earnings

The Dow Jones Industrial Average rallied Wednesday, as software leader Salesforce surged on better-than-expected earning results.

Investors Business Daily

Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates

May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month, bringing the total for the year to 15. This compares to the 24 NMEs the Food and…

Benzinga

Germany's Merck To Launch Semiconductor Base In China

German semiconductor supplier of chemicals and materials Merck KGaA (OTC:MKKGY) forged a contract with local authorities to open a semiconductor base in China's Zhangjiagang, Reuters reports. The new 69-acre base will house production plants for thin-film materials and electronic specialty gasses, warehouses, and operation centers. Previously Merck disclosed plans to invest at least…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck

GlaxoSmithKline announced Tuesday a $3.3 billion deal to buy pneumonia vaccine-maker Affinivax. But GSK stock dipped at the close.

Investors Business Daily

Dow Jones Sells Off As Bitcoin Soars; Oil Prices Jump As EU Bans Russian Oil

The Dow Jones Industrial Average fell Tuesday. Bitcoin soared, while oil prices jumped to a two-month high on a partial Russian oil embargo.

Investors Business Daily

Merck Stock Had A Contrarian Nature In Weak Market

It's great for a stock to rise in a weak market. But if the market strengthens, its contrarian nature may work against it.

Investors Business Daily

Dow Jones Rallies On Inflation Data; 7 Top Stocks To Buy And Watch

The Dow Jones Industrial Average rose Friday on inflation data. Seven top stocks to buy and watch include Tesla supplier Livent.

Investors Business Daily

Dow Jones Rallies As Nvidia Slashes Losses; Twitter Jumps As Musk Raises Financing

The Dow Jones Industrial Average rose Thursday, as Nvidia slid on a weak outlook. Twitter jumped as Elon Musk raised his equity in the deal.

Investors Business Daily

Dow Jones Reverses Ahead Of Fed Minutes; Nvidia Earnings Next

The Dow Jones Industrial Average reversed Wednesday ahead of minutes from May's Fed meeting. Nvidia earnings are due out after the close.

Investors Business Daily

Dow Jones Falls As Snap Plunges 39% On Profit Warning

The Dow Jones Industrial Average dropped Tuesday, as Snap stock plunged 39% after issuing a profit and sales warning for the second quarter.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures Fall, Tech Futures Sell Off As Snap Crashes 30% On Q2 Warning

Dow Jones futures were lower, while tech futures sold off Tuesday, as Snap stock crashed 30% after issuing a second-quarter warning.

Irish Mirror

Biopharmaceutical company Merck to invest €440m and create 370 jobs in Cork over the next five years

The plans represent Merck’s biggest ever investment in a single site life sciences operation.

Investors Business Daily

Dow Jones Rallies As Stock Market Looks To Rebound; VMware Surges On Broadcom Talks

The Dow Jones Industrial Average rallied Monday, as the stock market looked to rebound from last week's heavy losses. VMware surged on Broadcom talks.

Benzinga

CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting

European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending Merck & Co Inc (NYSE:MRK) Keytruda in melanoma setting. The opinion covers Keytruda as a monotherapy adjuvant treatment for adults and adolescents aged 12 years and older with stage IIB or IIC melanoma and who have…

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Rallies As China Cuts Key Interest Rate; Ross Stores Plummets 22% On Earnings

The Dow Jones Industrial Average rallied Friday, as China's central bank cut a key interest rate. Ross Stores crashed 22% on weak earnings.

Investors Business Daily

Dow Jones Sells Off After Stock Market Dive; Cisco Plunges 14% On Earnings

The Dow Jones Industrial Average sold off Thursday, as Cisco Systems stock plunged 12% on weak earnings results.

Investors Business Daily

How Heart Drugs Could Pump $10 Billion Into Merck's Coffers

Merck stock has reinvigorated on the company's plans in heart disease. Will its efforts be enough as Keytruda goes off patent?

Benzinga

IO Biotech Starts Dosing In Late-Stage IO102-IO103/Keytruda Combo Trial In Melanoma Patients

IO Biotech (NASDAQ: IOBT) dosed first patient in its phase 3 clinical trial of lead drug candidate, IO102-IO103, in combination with Merck's KEYTRUDA® (pembrolizumab) in patients with previously untreated, unresectable or metastatic (advanced) melanoma.

Investors Business Daily

Dow Jones Sells Off As Target Plunges 25% On Earnings

The Dow Jones Industrial Average sold off Wednesday, as Target stock plunged 25% on weak earnings results.

Investors Business Daily

Dow Jones Futures Jump As Stock Market Rally Attempt Continues; Musk-Twitter Deal Still Happening?

Dow Jones futures were higher Tuesday, as the rally attempt continues. Elon Musk suggested a Twitter deal could come at a lower price.

Benzinga

Merck, Athenex Join Forces To Evaluate Oraxol/Keytruda Combo In Lung Cancer

Athenex Inc (NASDAQ:ATNX) announced a clinical trial collaboration and supply agreement with Merck Co & Inc (NYSE:MRK). The agreement applies to the expansion phase of the Phase 1 clinical trial evaluating Athenex's oral paclitaxel combined with Merck's Keytruda (pembrolizumab) for certain NSCLC patients. The agreement will support the trial's expansion phase to investigate further the…

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.